82-year-old man with calcified stenosis in left main artery who underwent coronary CTA by PCD CT

 

82-year-old man with calcified stenosis in left main artery who underwent coronary CTA by PCD CT. Curved multiplanar reformatted images at varying virtual monoenergetic imaging (VMI) levels (40-140 keV) show stenosis at each level. Percent diameter stenosis (PDS) decreased from 92.5% at 40 keV to 53.1% at 140 keV. Extent of calcium blooming artifacts decreased from 100.0% at 40 keV to 72.3% at 140 keV.


January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with virtual monoenergetic imaging (VMI) reconstruction can help overcome present limitations in stenosis quantification on coronary CTA.

“When performing coronary CTA by PCD CT, the selection of VMI level influences stenosis assessment in calcified and mixed plaque, thereby potentially impacting clinical decision-making,” wrote corresponding author Tilman Emrich, MD, from the department of diagnostic and interventional radiology at Germany’s University Medical Center in Mainz.

In this AJR accepted manuscript, a phantom containing two custom-made vessels (25% and 50% stenoses) underwent PCD CT acquisitions without and with simulated cardiac motion. A retrospective analysis was performed of 33 patients (7 female, 26 male; mean age, 71 years; 64 coronary artery stenoses) who underwent coronary CTA by PCD CT followed by invasive coronary angiography (ICA). Scans were reconstructed at nine VMI levels (40–140 keV). Percentage diameter stenosis was measured, and bias was determined from the ground-truth stenosis percentage in the phantom and ICA-derived quantitative coronary angiography measurements in patients. Extent of blooming artifacts was measured in the phantom and in calcified and mixed plaques in patients.

Ultimately, for coronary CTA performed by PCD CT, stenosis percentage and calcium blooming artifacts decreased with increasing VMI level in calcified and mixed plaque. Stenosis measurement exhibited lowest bias, using invasive angiography as reference, at 100, 140, and 40 keV for calcified, mixed, and non-calcified plaque, respectively.

“To our knowledge,” Emrich et al. added, “this study is the first in vivo study to investigate the influence of different VMI levels on stenosis quantification of PCD CT in comparison with ICA as the reference standard.”

For more information: www.arrs.org


Related Content

News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Imaging

March 2, 2026 — Esaote Group will officially launch the new MyLab E85 and MyLab C30 GTS Edition ultrasound systems at ...

Time March 02, 2026
arrow
News | Remote Viewing Systems

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...

Time February 27, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | ARRS

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Time February 13, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 9, 2026 — MRIguidance, a MedTech company developing BoneMRI, a radiation-free bone imaging solution, has appointed ...

Time February 09, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Interventional Radiology

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 02, 2026
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Nov. 26, 2025 — a2z Radiology AI has received U.S. FDA clearance for a2z-Unified-Triage, a single device that flags and ...

Time December 03, 2025
arrow
Subscribe Now